Mercy Health settles what's called a False Claims Act, which fines companies, often in healthcare or pharmaceutical fields, for defrauding governmental programs.
Blog
The U.S. has opened a criminal investigation into whether traders manipulated prices in the $550 billion market for unsecured bonds issued by Fannie Mae and Freddie Mac, according to people familiar with the matter.
The lawsuit was brought under the qui tam, or whistleblower, provisions of the False Claims Act by three former employees of Inchcape.
The judgment follows the January 31, 2018, jury verdict finding the three individuals liable for violating the False Claims Act (FCA) by paying remuneration to physicians in exchange for patient referrals, in violation of the Anti-Kickback Statute, and causing two laboratories to bill federal health care programs for medically unnecessary testing.
A federal jury found a physician guilty today for her role in a scheme involving approximately $8.9 million in fraudulent Medicare claims for home health care and other physician services that were procured through the payment of kickbacks, were not medically necessary, not actually provided or, in some cases, were provided by the defendant, who was not a licensed physician during the conspiracy.
Pfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare patients, covering their out-of-pocket costs for its prescription drugs.
Cambridge Analytica whistle-blower Christopher Wylie said Facebook Inc. Chief Executive Officer Mark Zuckerberg engaged in "a spectacle of non-answers" in testimony before U.S. and European lawmakers that would increase the chances the social network will face regulation and further harm the trust of its users.
The scheme is alleged to have resulted a loss of up to $1.8 million to the Medicare program by submitting claims to Medicare from 2013 through 2017 related to Medicare beneficiary information that he obtained by paying illegal kickbacks.
A former Valeant Pharmaceuticals International Inc. executive was found guilty of accepting a $10 million bribe for manipulating the company's takeover of a startup mail-order pharmacy in 2014 -- the latest fallout from a scandal that shook the drugmaker.
GlaxoSmithKline is facing fresh criticism over the way it treats whistleblowers after a lawsuit was filed by a former senior technical lead claiming he was harassed and wrongfully dismissed after repeatedly warning over issues with the pharmaceutical giant's computer fleet.
The Justice Department and the Virginia attorney general's office are jumping in to a whistleblower's lawsuit alleging a subcontractor deliberately used bad concrete on a $2.6 billion project to extend the D.C. region's Metrorail system to Dulles International Airport.
The Securities and Exchange Commission is pitching a fake initial coin offering to educate investors on the pitfalls of too-good-to-be-true ventures. The bogus digital currency, called HoweyCoins, has a sleek website, complete with a white paper, and pictures of made-up celebrity promoters and luxurious destinations. The token's backers anticipate at least 1 percent daily returns and a hedge against inflation by combining "the magic of coin trading profits and the excitement and guaranteed returns of the travel industry.
Prosecutors have already charged Insys founder John Kapoor and won guilty pleas from two characters in an ongoing kickbacks probe. Now, the Justice Department has escalated the case by joining in with whistleblowers who've detailed a stunning range of techniques the company allegedly used to push its powerful opioid painkiller.
The U.S. Department of Justice has joined whistleblower litigation accusing Insys Therapeutics Inc of trying to generate more profit by paying kickbacks to doctors to prescribe powerful opioid medications.
The U.S. Supreme Court turned away an appeal from the first commodities trader convicted of spoofing since Congress made it a crime, rejecting arguments that the 2010 ban is so vague it should be overturned. The justices, without comment Monday, left intact a three-year prison sentence imposed on Michael Coscia, the former principal of Panther Energy Trading.
The regulatory findings will also be closely read by lawmakers keen to ensure top banking officials are held accountable for their actions at a time when there are growing calls to better protect whistleblowers.
A heavy weight has finally been lifted off the shoulders of Royal Bank of Scotland CEO Ross McEwan. The British bank said today that it agreed to pay $4.9 billion to the US Justice Department to settle an investigation into RBS's mis-selling of mortgage securities in the run-up to the global financial crisis.
A former Massachusetts man who ran what prosecutors called a Ponzi-style scheme that defrauded 15 investors out of more than $6 million has been convicted.
Some of the biggest names on Wall Street are warming up to Bitcoin, a virtual currency that for nearly a decade has been consigned to the unregulated fringes of the financial world.
Wells Fargo & Co. agreed to pay $480 million to settle a class-action lawsuit in which investors accused the bank of securities fraud related to its fake-account scandal. The settlement resolves the main class-action suit brought by shareholders targeting the bank's allegedly deficient disclosures related to its sales practices. It had previously set aside reserves for the settlement, according to a regulatory filing Friday. Wells Fargo said in a statement that it denies the allegations in the suit.
